SGLT2 Inhibitors – The New Standard of Care for Cardiovascular, Renal and Metabolic Protection in Type 2 Diabetes: A Narrative Review
| Date first appeared online | 05/04/2024 |
| DOI | 10.1007/s13300-024-01550-5 |
| Authors | Bain S. |
| Journal Name | Diabetes Therapy |
| Volume | 15 |
Documents
- 65982.pdf , Book, © The Author(s) 2024. This article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.